Brief: Medcap Divests Vitamin D

MedCap AB (publ)

22/07/2022 08:22

July 22 (Reuters) - MedCap AB (publ)  MEDCAP.ST :
    * MEDCAP DIVESTS VITAMIN D
    * SALES PRICE AND CAPITAL GAIN AMOUNT TO 20 MSEK AND
GENERATES A
POSITIVE ONE-TIME EFFECT IN Q3
    * MEDCAP AB (PUBL) HAS, THROUGH ITS SUBSIDIARY UNIMEDIC
PHARMA AB,
SIGNED AN AGREEMENT TO DIVEST RIGHTS TO PRODUCT VITAMIN D TO
PHARMAPRIM AB
    * IN 2021, PRODUCT'S SALES AMOUNTED TO 3.2 MSEK AND
DIVESTMENT IS
EXPECTED TO HAVE A MARGINAL EFFECT ON MEDCAP'S SALES AND
PROFITABILITY
    * SALE SUPPORTS FOCUS OF COMPANY'S SPECIALTY PHARMA
PORTFOLIO

Source text for Eikon:  ID:nWkr9pbyx0 
Further company coverage:  MEDCAP.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))